findmyKOL

Benjamin Scirica, MD

Enriched profile

Professor of Medicine, Harvard Medical School; Director of Innovation, Cardiovascular Division, Brigham and Women's Hospital · Brigham and Women's Hospital

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyCardiovascular DiseaseFocusDyslipidemia / Lipid Disorders
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Benjamin Scirica is Professor of Medicine, Harvard Medical School; Director of Innovation, Cardiovascular Division, Brigham and Women's Hospital at Brigham and Women's Hospital. OpenAlex indexes 462 publications with 30,530 citations (h-index 72); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.

Data verified 15 Oct 2026

Overview

Updated 16 Oct 2026

Benjamin Scirica, MD, is Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital. The public record shows 462 publications with 30,530 citations (h-index 72), centered on Dyslipidemia / Lipid Disorders. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 9 companies.

  • Most recent indexed publication: 2026 · Circulation. Heart failure
  • Top research focus: Dyslipidemia / Lipid Disorders
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 9 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Cardiovascular Diseases1 trialVascular Diseases1 trialDyslipidemia / Lipid Disorders1 trialHeart Failure1 trial

Research focus

OpenAlex concept fingerprint
Dyslipidemia / Lipid Disorders

Drugs & molecules

across trials, industry payments and publications
Jardiancegeneric · EmpagliflozinClinical trials—Industry payments2Publications—Ozempicgeneric · SemaglutideClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Merck Sharp & Dohme LLCClinical trials—Industry payments81Novo Nordisk ASClinical trials—Industry payments32Boehringer Ingelheim International GmbHClinical trials—Industry payments8Amgen Inc.Clinical trials—Industry payments7Novo Nordisk IncClinical trials—Industry payments7Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments5AstraZeneca UK LimitedClinical trials—Industry payments3Brigham and Women's HospitalClinical trials3Industry payments—E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments1Eli Lilly and CompanyClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
462publications

Distinct works indexed by OpenAlex, matched via ORCID; 13 in PubMed.

30,530citations

Total citations across indexed works.

72h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
9companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    82.5%
    Statin20.6%
    Atorvastatin Calcium50%Rosuvastatin Calcium50%
    Part D≥24 patients
    Beta blocker15.6%
    Metoprolol Succinate62%Carvedilol38%
    Part D≥29 patients

    + 12 more classes in this area

  • Blood & clotting

    11%
    Factor Xa inhibitor6.4%
    Eliquis100%
    Part D≥16 patients
    P2Y12 inhibitor4.5%
    Clopidogrel100%
    Part D≥11 patients
  • Metabolism & gastrointestinal

    6.6%
    SGLT2 inhibitor5%
    Jardiance100%
    Part D≥14 patients
    GLP-1 receptor agonist1.6%
    Mounjaro100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/benjamin-scirica-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Benjamin-M-Scirica-39120251

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/bscirica

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Other

    timi.org/2023/04/28/timi-talks-episode-5-with-dr-ben-scirica

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →timi.org ↗
  • Other

    acc.org/latest-in-cardiology/articles/2018/06/26/07/57/accel-lite-2018june-p2

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acc.org ↗
  • LinkedIn

    LinkedIn: Ben Scirica - Cardiologist, Clinical Trialist

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • Doximity

    Doximity profile: Dr. Benjamin Scirica, MD - Boston, MA - Cardiology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Director of Innovation

    Cardiovascular Division, Brigham and Women's Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
  • Senior Investigator

    TIMI Study Group

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →timi.org ↗
  • Lead

    Accelerator for Clinical Transformation, Mass General Brigham

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →accelerator.massgeneralbrigham.org ↗
  • Attending Physician

    Levine Cardiac Intensive Care Unit and Watkins Cardiovascular Clinic, Brigham and Women's Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.